Building new pharma facilities or optimizing existing ones - from start to finish
Read how NNE delivered a secure, tailored and customisable cloud solution with Amazon Web Services (AWS) for Novo Nordisk's device manufacturing site to improve accuracy and access to real-time data.
As of 1 January 2021, Sofie Jarl Mørck takes over as chief financial officer at NNE. Find out how she feels about her new role here.
We're trying to find out what the world outside of NNE thinks about us. So if you have a few minutes to spare today, your input would be much appreciated.
Unibio and NNE have entered into a strong digital partnership. The unique cooperation will benefit both Danish companies and the entire biotech industry.
Novo Nordisk's facility for cell-based and allogenic therapies had some unique challenges and solutions. Using this as a starting point, find out how we navigated the journey from R&D to clinical manufacturing in cell and gene therapy.
A four-step approach for remote and virtual GMP/GDP auditing to help you overcome restrictions and closed borders and meet cGMP needs in clinical trial supply or routine commercial operations.
Stay on top of Pharma 4.0. - get exclusive GMP advice, the latest insights from industry experts and invitations to our network events.
Home to around 1000 ambitious people, NNE is a playground for engineers who work hard to deliver the right answers to complex questions. Learn more about our employees and company culture, and see whether NNE could be the place for you.